CTOs on the Move

Bausch + Lomb

www.bausch.com

 
Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New ...
  • Number of Employees: 10K-50K
  • Annual Revenue: > $1 Billion
  • www.bausch.com
  • 400 Somerset Corporate Boulevard
    Bridgewater, NJ USA 08807
  • Phone: 866.246.8245

Executives

Name Title Contact Details
Peter Fourie
 SVP, Chief Information Officer Profile
Manisha Narasimhan
 Chief Corporate Development and Digital Officer Profile
Charles Frahm
 Executive Director and Chief Security Officer, Bausch and Lomb Profile

Similar Companies

Neotropix

Neotropix is a Malvern, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OmegaChem

OmegaChem is a Levis, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Stayma Consulting Services

Stayma Consulting Services is a Alpharetta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CoreRx Pharma

CoreRx, Inc. is an industry leading Contract Development and Manufacturing Organization (CDMO), providing innovative drug formulation development, GMP manufacturing and packaging solutions to global pharmaceutical and bio-pharmaceutical partners. From its state-of-the-art, multi-site campus in Clearwater, Florida and its early product development center of excellence in San Rafael, California, CoreRx delivers value-added solutions to its partners, from clinic to commercial scale and across a range of dosage forms.

ITM Isotope Technologies Munich SE

ITM Isotopen Technologien München AG and its subsidiaries develop, produce and supply innovative diagnostic and therapeutic radionuclides and radiopharmaceuticals.